BIOTECH TARGET N V - 05 Jan 2022 Form 4 Insider Report for Radius Health, Inc.

Role: 10%+ Owner
Signature: /s/Ivo Betschart
Issuer symbol: N/A
Transactions as of: 05 Jan 2022
Net transactions value: +$3,469,060
Form type: 4
Filing time: 07 Jan 2022, 10:33:19 UTC
Previous filing: 23 Nov 2021
Next filing: 10 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RDUS	Common Stock	Purchase	$1,574,650	+250,000	+3.2%	$6.30	7,955,714	05 Jan 2022	Direct
transaction	RDUS	Common Stock	Purchase	$1,894,410	+300,000	+3.8%	$6.31	8,255,714	06 Jan 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Radius Health, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.